Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2015

Anti-VEGF Treatment of Diabetic Macular Edema in Clinical Practice

Steven Yeh, MD, Kevin J. Blinder, MD

Show Description +

Kevin J. Blinder, MD, of the Retina Institute in St. Louis, explains the details of a retrospective analysis of real-world treatment of diabetic macular edema. Patients in the study, all of whom received ranibizumab or bevacizumab treatments, were evaluated for visual and anatomic changes.

Posted: 7/10/2015

Up Next

OSPREY and OWL: A Pair of Phase 2 Clinical Trials Evaluating RTH258 for Neovascular AMD

OSPREY and OWL: A Pair of Phase 2 Clinical Trials Evaluating RTH258 for Neovascular AMD

Rishi P. Singh, MD

Complications Associated with PVR Surgery: New Approaches

Complications Associated with PVR Surgery: New Approaches

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

Preview to the ASRS Annual Meeting in Vienna

Preview to the ASRS Annual Meeting in Vienna

Carl Regillo, MD, Jonathan L. Prenner, MD

Vitrectomy for DME in Treatment-Naïve Eyes

Vitrectomy for DME in Treatment-Naïve Eyes

Jerzy Nawrocki, MD, PhD, Steven Yeh, MD

C3F8: A Good Alternative Treatment for Macular Holes and VMT

C3F8: A Good Alternative Treatment for Macular Holes and VMT

Calvin E. Mein, MD, Francesco Boscia, MD

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

Calvin E. Mein, MD, Francesco Boscia, MD

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

Intravitreal Injections: Do They Induce Trauma to the Lens?

Intravitreal Injections: Do They Induce Trauma to the Lens?

Paul Hahn, MD, PhD, Steven Yeh, MD

A Post Hoc Analysis of the RISE and RIDE Studies

A Post Hoc Analysis of the RISE and RIDE Studies

J. Michael Jumper, MD, Steven Yeh, MD

Back to All Videos

Anti-VEGF Treatment of Diabetic Macular Edema in Clinical Practice

Steven Yeh, MD, Kevin J. Blinder, MD

Kevin J. Blinder, MD, of the Retina Institute in St. Louis, explains the details of a retrospective analysis of real-world treatment of diabetic macular edema. Patients in the study, all of whom received ranibizumab or bevacizumab treatments, were evaluated for visual and anatomic changes.

Posted: 7/10/2015

Please log in to leave a comment.

More From ASRS: 2015 Coverage

Vitrectomy for DME in Treatment-Naïve Eyes

Vitrectomy for DME in Treatment-Naïve Eyes

Jerzy Nawrocki, MD, PhD, Steven Yeh, MD

C3F8: A Good Alternative Treatment for Macular Holes and VMT

C3F8: A Good Alternative Treatment for Macular Holes and VMT

Calvin E. Mein, MD, Francesco Boscia, MD

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

Calvin E. Mein, MD, Francesco Boscia, MD

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2015.